Intestinal perforation in recurrent cervical cancer following bevacizumab and pembrolizumab therapy: A case report.

Medicine (Baltimore) · 2025 · PMC11999440 · PMID 40228288

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, their study also noted an increasing trend in toxicity with the combination of nivolumab and bevacizumab.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.